ECSP045039A - ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS - Google Patents

ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS

Info

Publication number
ECSP045039A
ECSP045039A ECSP045039A ECSP045039A EC SP045039 A ECSP045039 A EC SP045039A EC SP045039 A ECSP045039 A EC SP045039A EC SP045039 A ECSP045039 A EC SP045039A
Authority
EC
Ecuador
Prior art keywords
compositions
intraoral
disgregation
organoleptically acceptable
organoleptically
Prior art date
Application number
Other languages
Spanish (es)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045039A publication Critical patent/ECSP045039A/en

Links

Abstract

La presente invención se refiere a composiciones farmacéuticas de disgregación intraoral que contienen un fármaco organolépticamente inaceptable como ingrediente activo, y a procesos para preparar dichas composiciones.The present invention relates to pharmaceutical intraoral disintegration compositions containing an organoleptically unacceptable drug as an active ingredient, and to processes for preparing said compositions.

ECSP045039 2001-09-26 2004-03-26 ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS ECSP045039A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33535601P 2001-09-26 2001-09-26

Publications (1)

Publication Number Publication Date
ECSP045039A true ECSP045039A (en) 2004-04-28

Family

ID=40435086

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP045039 ECSP045039A (en) 2001-09-26 2004-03-26 ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS

Country Status (1)

Country Link
EC (1) ECSP045039A (en)

Similar Documents

Publication Publication Date Title
ECSP083351A (en) PHARMACEUTICAL COMPOSITIONS
ES2156603T3 (en) MEDICATIONS BASED ON A SYNTHETIC MIXTURE OF METRONIDAZOL AND CLINDAMYCIN.
BG66093B1 (en) Controlled release compositions comprising nimesulide
ECSP045029A (en) VALDECOXIB COMPOSITIONS OF INTRAORAL DISGREGATION
MY149623A (en) Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
HN2002000247A (en) SULFONAMIDE DERIVATIVES
BR0015188A (en) Pharmaceutical compositions
HK1096034A1 (en) A solid dosage form comprising a fibrate
LTPA2011011I1 (en) Stable pharmaceutical solution formulations for pressurized metered dose inhalers
MX2007015480A (en) Solid dosage formulations of narcotic drugs having improved buccal adsorption.
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
WO1999033793A3 (en) Prodrugs of aspartyl protease inhibitors
BR0306870A (en) Oral pharmaceutical composition and method for preparing the same
ECSP066860A (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
MXPA06011467A (en) Active substance combination comprising a carbinol combined to at least an nsaid.
CR8371A (en) DRUG FORMULATIONS CONTAINING FLAVORS WITH BETTER PHARMACEUTICAL PROPERTIES
SE0300831D0 (en) New formulations and use therof
PT1121127E (en) PHARMACEUTICAL COMPOSITIONS ORAIS CONTAINING BUPRENORFIN
AR048672A1 (en) DISINTEGRATION TABLETS THAT INCLUDE LICARBAZEPINA
DE60102590T2 (en) PHARMACEUTICAL FORMS FOR THE TREATMENT OF ORAL MYCOSES
EA201101119A1 (en) DOSABLE FORM CONTAINING PANTOPRAZOL AS AN ACTIVE INGREDIENT
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
BR0306843A (en) Sedative formulations of non-benzodiazepine
DE60111503D1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TERBINAFIN
ECSP045039A (en) ORGANOLEPTICALLY ACCEPTABLE INTRAORAL DISGREGATION COMPOSITIONS